TG Therapeutics, Inc

(NASDAQ:TGTX)

Latest On TG Therapeutics, Inc (TGTX):

Date/Time Type Description Signal Details
2023-05-06 07:44 ESTNewsTG Therapeutics' Stock Surge: Exploring The Factors And Exercising Caution (Rating Upgrade)N/A
2023-05-02 02:37 ESTNewsTG Therapeutics jumps 19% to hit 52-week high after Q1 beat (update)N/A
2023-05-01 14:23 ESTNewsTG Therapeutics GAAP EPS of -$0.28 beats by $0.07, revenue of $7.8M beats by $4.42MN/A
2023-05-01 14:23 ESTNewsTG Therapeutics slips despite Q1 beatN/A
2023-05-01 14:22 ESTNewsTG Therapeutics, Inc. (TGTX) Q1 2023 Earnings Call TranscriptN/A
2023-04-29 00:22 ESTNewsTG Therapeutics: A Plethora Of Good News, Strong Revenues ExpectedN/A
2023-04-27 23:34 ESTNewsTG Therapeutics gains after reimbursement win for multiple sclerosis therapyN/A
2023-04-11 19:18 ESTNewsTG Therapeutics extends rally to hit 52-week high after B. Riley commentsN/A
2023-04-11 19:18 ESTNewsHot Stocks: TLRY drops on earnings; MARA, MSTR, RIOT, COIN boosted by crypto rise; PSMT gains; MRNA fallsN/A
2023-04-11 04:01 ESTNewsTG Therapeutics jumps 22% as Cantor cites strong Briumvi salesN/A
2023-03-31 11:03 ESTNewsTG Therapeutics' multiple sclerosis drug Briumvi gets EMA panel backingN/A
2023-03-22 17:59 ESTNewsTG Therapeutics' Briumvi Has Potential For Growth In A Crowded MarketN/A
2023-03-20 19:43 ESTNewsTG Therapeutics: That ICER Report Doesn't Bother MeN/A
2023-03-09 23:16 ESTNewsTG Therapeutics’ price for multiple sclerosis therapy is not low enough - ICERN/A
2023-03-01 01:53 ESTNewsTG Therapeutics, Inc. (TGTX) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 10:24 ESTNewsTG Therapeutics GAAP EPS of -$0.39 misses by $0.14, revenue of $0.08M misses by $1.52MN/A
2023-02-27 20:17 ESTNewsTG Therapeutics Q4 2022 Earnings PreviewN/A
2023-02-23 20:12 ESTNewsTG Therapeutics' Briumvi: A Tough Sell For Multiple Sclerosis Treatment MarketN/A
2023-02-07 11:09 ESTNewsTG Therapeutics up as Cantor sees a “strong launch” for multiple sclerosis therapyN/A
2023-02-01 21:47 ESTNewsTG Therapeutics: Strategy After Briumvi LaunchN/A
2023-01-26 12:41 ESTNewsTG Therapeutics launches newly approved multiple sclerosis therapyN/A
2023-01-11 14:59 ESTNewsTG Therapeutics adds 10% to extend gains after insider purchaseN/A
2023-01-02 17:51 ESTNewsTG Therapeutics: Ramifications Of Briumvi ApprovalN/A
2022-12-29 23:50 ESTNewsTG Therapeutics surges as focus turns to launch of new multiple sclerosis therapyN/A
2022-12-28 18:27 ESTNewsTG Therapeutics jumps 19% as FDA approves multiple sclerosis therapyN/A
2022-12-24 22:09 ESTNewsStocks To Watch: Nio, Tesla And Hopes For A Santa Clause RallyN/A
2022-12-17 21:07 ESTNewsIt's almost 2023, but here are the drugs the FDA could approve before the end of the yearN/A
2022-12-15 16:42 ESTNewsTG Therapeutics: Ublituximab Could Achieve $1 Billion In Annual Sales By Year-End 2024N/A
2022-12-14 23:31 ESTNewsTG Therapeutics: Would Santa Deliver An Early Present?N/A
2022-11-13 05:29 ESTNewsTG Therapeutics (TGTX) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 23:59 ESTNewsTG Therapeutics GAAP EPS of -$0.26 beats by $0.07, revenue of $0.09M misses by $1.61MN/A
2022-11-10 23:59 ESTNewsTG Therapeutics jumps 56% amid FDA labeling talks for multiple sclerosis therapyN/A
2022-10-09 13:35 ESTNewsTG Therapeutics: Elucidating The Upcoming BinaryN/A
2022-09-21 15:15 ESTNewsTG Therapeutics: We Are Just Hanging In ThereN/A
2022-08-25 19:03 ESTNewsTG Therapeutics announces peer-reviewed publication of multiple sclerosis phase 3 trialsN/A
2022-08-09 08:40 ESTNewsTG Therapeutics stock soars 18% on Q2 beat as net loss narrows; eyes MS drug win by year-endN/A
2022-08-09 08:40 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 09:01 ESTNewsTG Therapeutics GAAP EPS of -$0.30 beats by $0.17, revenue of $0.6M beats by $0.42MN/A
2022-08-06 00:27 ESTNewsTG Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-09 02:04 ESTNewsTG Therapeutics And Ublituximab: From Icing To LifelineN/A
2022-06-01 21:32 ESTNewsTG Therapeutics slips as FDA withdraws approval for cancer drugN/A
2022-05-31 12:26 ESTNewsTG Therapeutics announces delay in FDA review for multiple sclerosis drugN/A
2022-05-21 18:22 ESTNewsTG Therapeutics initiated at BofA with a bearish view on multiple sclerosis drugN/A
2022-04-22 18:32 ESTNewsTG Therapeutics: Can The Company Successfully Turn Around?N/A
2022-04-18 21:06 ESTNewsTG Therapeutics: I May Double Down AgainN/A
2022-04-18 21:06 ESTNewsTG Therapeutics extends losses as H.C. Wainwright slashes target on Ukoniq setbackN/A
2022-04-18 06:43 ESTNewsTG Therapeutics stock falls 24% as it withdraws Ukoniq from sale, pulls filing with FDAN/A
2022-03-03 18:32 ESTNewsTG Therapeutics stock falls as FDA extends review of blood cancer drug comboN/A
2022-03-01 13:48 ESTNewsTG Therapeutics GAAP EPS of -$0.70 misses by $0.08, revenue of $2.32M beats by $0.08MN/A
2022-03-01 13:47 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q4 2021 Results - Earnings Call TranscriptN/A

About TG Therapeutics, Inc (TGTX):

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. The company is headquartered in New York, New York.

See Advanced Chart

General

  • Name TG Therapeutics, Inc
  • Symbol TGTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 272
  • Last Split Factor100:5625
  • Last Split Date2012-04-30
  • Fiscal Year EndDecember
  • IPO Date1995-12-14
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.tgtherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 36580.51
  • Price/Book (Most Recent Quarter) 13.05
  • Enterprise Value Revenue 40882.96
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.06
  • Next Year EPS Estimate -$0.80
  • Next Quarter EPS Estimate -$0.50
  • Operating Margin -179996%
  • Return on Assets -43%
  • Return on Equity -100%
  • Revenue 152000
  • Earnings Per Share -$1.96
  • Revenue Per Share $0
  • Gross Profit 152000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 6.47 billion
  • EBITDA -158616992
  • PE Ratio 37.85
  • Analyst Target Price $75.33
  • Book Value Per Share $4.00
View More

Share Statistics

  • Shares Outstanding 137.81 million
  • Shares Float 120.36 million
  • % Held by Insiders 713%
  • % Held by Institutions 67.24%
  • Shares Short 11.84 million
  • Shares Short Prior Month 11.76 million
  • Short Ratio 8
  • Short % of Float 10%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 2.13
  • 52 Week High $56.74
  • 52 Week Low $7.12
  • 50 Day Moving Average 46.97
  • 200 Day Moving Average 37.82
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

TG Therapeutics, Inc (TGTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

TG Therapeutics, Inc (TGTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$38000-$0.72-$0.58-23.78%
2020-09-302020-11-09$N/A-$0.73-$0.41-76.76%
2020-06-302020-08-10$N/A-$0.47-$0.34-39.05%
2020-03-312020-05-11$38000-$0.48-$0.36-34.08%
2019-12-312020-03-02$38000-$0.44-$0.42-5.39%
2019-09-302019-11-12$38000-$0.69-$0.34-104.44%
2019-06-302019-08-09$38000-$0.42-$0.444.55%
2019-03-312019-05-10$38000-$0.43-$0.441.15%
2018-12-312019-03-01$38000-$0.69-$0.44-55.41%
2018-09-302018-11-09$38000-$0.43-$0.5420.37%
2018-06-302018-08-07$38000-$0.59-$0.53-12.38%
2018-03-312018-05-08$38000-$0.59-$0.44-34.09%
2017-12-312018-03-08$38000-$0.46-$0.44-4.14%
2017-09-302017-11-08$38000-$0.48-$0.43-11.63%
2017-06-302017-08-09$38000-$0.45-$0.43-5.26%
2017-03-312017-05-05$38000-$0.52-$0.41-27.45%
2016-12-312017-03-10$38000-$0.48-$0.36-33.33%
2016-09-302016-11-07$38000-$0.50-$0.31-61.29%
2016-06-302016-08-08$38000-$0.33-$0.29-15.79%
2016-03-312016-05-10$38000-$0.28-$0.3621.5%
2015-12-312016-03-07$38000-$0.37-$0.32-16.83%
2015-09-302015-11-09$38000-$0.28-$0.3417.65%
2015-06-302015-08-10$38000-$0.38-$0.30-26.67%
2015-03-312015-05-04$38000-$0.39-$0.33-18.18%
2014-12-312015-03-11$38000-$0.48-$0.26-84.62%
2014-09-302014-11-10$38000-$0.51-$0.32-59.38%
2014-06-302014-07-21$38000-$0.32-$0.24-33.33%
2014-03-312014-05-12$38000-$0.25-$0.18-38.89%
2013-12-312014-03-05$38000-$0.19-$0.17-11.76%
2013-09-302013-11-11$38000-$0.16-$0.2227.27%
2013-06-302013-08-01$38000-$0.29-$0.16-81.25%
2013-03-312013-05-14$38000-$0.17-$0.15-13.33%
2012-12-312013-03-12$19000-$0.12-$0.137.69%
2012-09-302012-11-08$N/A-$0.16-$0.12-33.33%
2012-06-302012-08-09$N/A-$0.16-$0.06-166.67%
2012-03-312012-05-21$N/A-$2.03
2011-09-302011-11-14$N/A-$9.05
2011-06-302011-08-15$N/A-$64.63
2011-03-312011-05-23$N/A$84.58
2010-12-312011-03-02$N/A$9.18
2010-09-302010-11-15$N/A$0.96
2010-06-302010-08-16$N/A$43.21
2010-03-312010-05-24$N/A-$54.27
2009-12-312010-03-03$N/A-$8.88
2009-09-302009-11-16$N/A-$16.57
2009-06-302009-08-14$N/A-$55.45
2009-03-312009-05-19$N/A-$30.34
2008-12-312009-02-25$N/A$5.06
2008-09-302008-12-03$N/A-$55.53
2008-06-302008-08-19$N/A-$56.64
2008-03-312008-05-20$N/A-$62.10
2007-09-302007-11-14$N/A-$112.50-$28.12-300.07%
2007-06-302007-07-09$N/A-$112.50-$84.37-33.34%
2007-03-312007-05-15$N/A-$119.73
2006-09-302006-11-14$N/A-$84.37-$84.370%
2006-06-302006-08-14$N/A-$112.50-$112.500%
2006-03-312006-05-15$N/A-$140.62-$140.620%
2005-09-302005-09-30$N/A-$118.85
2005-06-302005-06-30$N/A-$934.25
2005-03-312005-03-31$N/A-$152.43
2004-12-312004-12-31$N/A-$196.87
2004-09-302004-09-30$N/A-$240.39
2004-06-302004-06-30$N/A-$109.61
2004-03-312004-03-31$N/A-$140.65
2003-12-312003-12-31$N/A-$225.00
2003-09-302003-09-30$N/A-$391.61
2003-06-302003-06-30$N/A-$93.46
2003-03-312003-03-31$N/A-$91.67
2002-09-302002-09-30$N/A-$507.41
2002-06-302002-06-30$N/A$24.21
2002-03-312002-03-31$N/A-$552.10
2001-09-302001-09-30$N/A-$1,528.45
2001-06-302001-06-30$-2712000-$4,513.55
2001-03-312001-03-31$2.71 million$1,855.58
2000-09-302000-09-30$1.07 million-$2,621.34
2000-06-302000-06-30$1.44 million-$7,888.48
2000-03-312000-03-31$925000-$5,766.57
1999-09-301999-09-30-$986.48
1999-06-301999-06-30-$1,929.43
1999-03-311999-03-31-$2,666.06
1998-09-301998-09-30-$5,140.91
1998-06-301998-06-30$695.14
1998-03-311998-03-31-$9,885.89

TG Therapeutics, Inc (TGTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

TG Therapeutics, Inc (TGTX) Chart:

TG Therapeutics, Inc (TGTX) News:

Below you will find a list of latest news for TG Therapeutics, Inc (TGTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

TG Therapeutics, Inc (TGTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-01-1610CALL0 4755.41TRUE00
2026-01-1620CALL0 0580.95TRUE00
2026-01-16326.67CALL0 230TRUE00
2026-01-16425.93CALL10 112822.42TRUE0.240.01
2026-01-16526.72CALL0 6660TRUE00
2026-01-16822.7CALL0 231361.67TRUE00
2026-01-161019.5CALL1 223340.79TRUE-0.5-0.03
2026-01-161217.57CALL1 301305.55TRUE17.570
2026-01-161514.95CALL0 655209.34TRUE00
2026-01-16160CALL0 00TRUE00
2026-01-161712.14CALL14 499174.41TRUE12.140
2026-01-161813.8CALL0 133146.04TRUE00
2026-01-161912.34CALL0 31115.8TRUE00
2026-01-162011CALL0 2195152.27TRUE00
2026-01-16219CALL0 102130.1TRUE00
2026-01-16227.4CALL422 1009492.34TRUE-0.7-0.09
2026-01-162310.4CALL0 730TRUE00
2026-01-16247.4CALL0 11097.24TRUE00
2026-01-16255.5CALL0 164378.47TRUE00
2026-01-16263.75CALL10 8575.46TRUE3.750
2026-01-16273.61CALL0 5670.47TRUE00
2026-01-16282.15CALL1 46764.75TRUE2.150
2026-01-16291.5CALL6 20972.4TRUE-0.49-0.25
2026-01-16301.15CALL32 321365.76FALSE-0.45-0.28
2026-01-16310.84CALL3 50467.8FALSE-0.31-0.27
2026-01-16320.57CALL33 87967.59FALSE-0.18-0.24
2026-01-16330.4CALL6 79669.04FALSE-0.19-0.32
2026-01-16340.35CALL1 40775.77FALSE00
2026-01-16350.25CALL49 421376.97FALSE-0.08-0.24
2026-01-16360.15CALL103 108774.97FALSE0.150
2026-01-16370.25CALL0 520133.94FALSE00
2026-01-16380.15CALL0 1408162.51FALSE00
2026-01-16390.24CALL0 72126.13FALSE00
2026-01-16400.09CALL135 336392.6FALSE-0.04-0.31
2026-01-16410.22CALL0 39186.55FALSE00
2026-01-16420.1CALL0 163203.47FALSE00
2026-01-16430.2CALL0 187185.26FALSE00
2026-01-16440.15CALL0 14230.36FALSE00
2026-01-16450.1CALL0 1630141.97FALSE00
2026-01-16460.2CALL0 10235.32FALSE00
2026-01-16470.15CALL0 194131.33FALSE00
2026-01-16480.05CALL0 59135.97FALSE00
2026-01-16490CALL0 0251.24FALSE00
2026-01-16500.06CALL1 1585133.87FALSE0.060
2026-01-16550.22CALL0 669310.38FALSE00
2026-01-16600.04CALL0 1009183.11FALSE00
2026-01-1610.04PUT2 2840.99FALSE0.010.33
2026-01-1620PUT0 00FALSE00
2026-01-1630PUT0 100FALSE00
2026-01-1640.08PUT0 181342.96FALSE00
2026-01-1650.09PUT0 453432.95FALSE00
2026-01-1680.05PUT0 207714.46FALSE00
2026-01-16100.05PUT0 340320.19FALSE00
2026-01-16120.05PUT0 154270.11FALSE00
2026-01-16150.03PUT1 365160.7FALSE0.022
2026-01-16160.63PUT0 11203.21FALSE00
2026-01-16170.8PUT0 297185.76FALSE00
2026-01-16181.15PUT0 1169.23FALSE00
2026-01-16190.11PUT0 8153.49FALSE00
2026-01-16200.05PUT1 195105.39FALSE0.050
2026-01-16210.4PUT0 18131.04FALSE00
2026-01-16220.1PUT0 1020116.52FALSE00
2026-01-16230.25PUT0 566117.71FALSE00
2026-01-16240.26PUT20 5689.64FALSE0.260
2026-01-16250.3PUT50 298779.51FALSE0.050.2
2026-01-16260.46PUT28 25677.03FALSE0.110.31
2026-01-16270.65PUT194 16672.7FALSE0.150.3
2026-01-16280.95PUT237 44970.45FALSE0.050.06
2026-01-16291.47PUT30 169542.11FALSE0.320.28
2026-01-16302PUT186 215273.32TRUE0.350.21
2026-01-16311.92PUT0 31565.39TRUE00
2026-01-16322.99PUT0 28947.42TRUE00
2026-01-16333.7PUT0 53469.99TRUE00
2026-01-16343.85PUT0 49754.57TRUE00
2026-01-16355.78PUT15 43559.55TRUE0.280.05
2026-01-16365.82PUT0 500TRUE00
2026-01-16376.34PUT0 8794.62TRUE00
2026-01-16387.24PUT0 52102.23TRUE00
2026-01-16397PUT0 31109.5TRUE00
2026-01-164010PUT0 2830TRUE00
2026-01-16417.3PUT0 15117.27TRUE00
2026-01-164211.5PUT0 115108.16TRUE00
2026-01-16430PUT0 0122.42TRUE00
2026-01-16440PUT0 0119.15TRUE00
2026-01-164513PUT0 0124.39TRUE00
2026-01-16460PUT0 0138.84TRUE00
2026-01-164717.93PUT0 0134.4TRUE00
2026-01-16480PUT0 0139.2TRUE00
2026-01-16490PUT0 0143.87TRUE00
2026-01-165016.6PUT0 1248158.57TRUE00
2026-01-16550PUT0 0169.54TRUE00
2026-01-16600PUT0 0188.43TRUE00
2026-02-201517CALL0 3489.7TRUE00
2026-02-201617.18CALL0 10TRUE00
2026-02-20170CALL0 082.64TRUE00
2026-02-20180CALL0 063.99TRUE00
2026-02-20190CALL0 066.48TRUE00
2026-02-20209.45CALL40 31359.03TRUE9.450
2026-02-202110.35CALL0 2673.31TRUE00
2026-02-20228.5CALL0 20765.12TRUE00
2026-02-20237.93CALL0 1379.46TRUE00
2026-02-20248.45CALL0 9075.47TRUE00
2026-02-20256.1CALL0 18072.34TRUE00
2026-02-20265.3CALL0 6571.13TRUE00
2026-02-20275.65CALL0 22783.04TRUE00
2026-02-20283.2CALL6 13658.83TRUE-0.4-0.11
2026-02-20293.2CALL0 8060.38TRUE00
2026-02-20302.3CALL11 79260.37FALSE-0.3-0.12
2026-02-20311.85CALL101 30458.95FALSE1.850
2026-02-20322.07CALL0 14359.16FALSE00
2026-02-20331.5CALL0 80661.94FALSE00
2026-02-20340.95CALL6 52757.63FALSE-0.25-0.21
2026-02-20350.85CALL7 47360.43FALSE-0.14-0.14
2026-02-20360.85CALL0 33759.31FALSE00
2026-02-20370.75CALL0 13969.07FALSE00
2026-02-20380.71CALL0 43668.6FALSE00
2026-02-20390.72CALL0 2264.02FALSE00
2026-02-20400.3CALL16 50961.9FALSE-0.05-0.14
2026-02-20410.75CALL0 370.41FALSE00
2026-02-20422.35CALL0 11137.71FALSE00
2026-02-20430.5CALL0 65140.68FALSE00
2026-02-20450.3CALL30 15978.2FALSE0.30
2026-02-20500.14CALL11 15079.38FALSE-0.01-0.07
2026-02-20550.15CALL10 15591.39FALSE0.030.25
2026-02-20150.2PUT0 9241.52FALSE00
2026-02-20160PUT0 0195.68FALSE00
2026-02-20170.63PUT0 0210.09FALSE00
2026-02-20180.43PUT0 397.41FALSE00
2026-02-20190.43PUT0 195.61FALSE00
2026-02-20200.23PUT1 1575.01FALSE0.230
2026-02-20210PUT0 073.68FALSE00
2026-02-20220.4PUT0 3150.46FALSE00
2026-02-20231.46PUT0 765.41FALSE00
2026-02-20240.75PUT2 7168.09FALSE0.750
2026-02-20251PUT5 12867.51FALSE10
2026-02-20261.13PUT1 4461.95FALSE1.130
2026-02-20271.25PUT0 22962.84FALSE00
2026-02-20281.65PUT0 28570.25FALSE00
2026-02-20292.5PUT1 15864.24FALSE2.50
2026-02-20303.02PUT2 35663.52TRUE0.570.23
2026-02-20312.77PUT0 3659.3TRUE00
2026-02-20323.35PUT0 1846.31TRUE00
2026-02-20334.9PUT10 3561.08TRUE0.60.14
2026-02-20344.55PUT0 35858.06TRUE00
2026-02-20356.13PUT15 18650.55TRUE6.130
2026-02-20366.32PUT0 5652.47TRUE00
2026-02-20376.85PUT0 2974.44TRUE00
2026-02-20387.65PUT0 276.08TRUE00
2026-02-20397.3PUT0 660.85TRUE00
2026-02-204010.16PUT0 8169.51TRUE00
2026-02-20418.8PUT0 575.58TRUE00
2026-02-20420PUT0 069TRUE00
2026-02-20430PUT0 072.35TRUE00
2026-02-204514.5PUT0 4690TRUE00
2026-02-20500PUT0 084.66TRUE00
2026-02-20550PUT0 0101.56TRUE00
2026-05-15150CALL0 072.38TRUE00
2026-05-152012.2CALL0 35684.63TRUE00
2026-05-152310.16CALL0 4780.2TRUE00
2026-05-15248.2CALL40 11878.19TRUE8.20
2026-05-15258CALL0 32978.37TRUE00
2026-05-15266.6CALL260 569.86TRUE6.60
2026-05-15278CALL0 772.46TRUE00
2026-05-15286.05CALL0 1972.11TRUE00
2026-05-15295.1CALL92 5269.08TRUE5.10
2026-05-15304.7CALL10 36469.33FALSE-0.4-0.08
2026-05-15314.2CALL2 4067.71FALSE4.20
2026-05-15323.9CALL1 15668.54FALSE3.90
2026-05-15333.7CALL0 7666.12FALSE00
2026-05-15343.9CALL0 1778.33FALSE00
2026-05-15353.2CALL0 11067.66FALSE00
2026-05-15362.5CALL1 2865.16FALSE2.50
2026-05-15373.01CALL0 664.49FALSE00
2026-05-15382.51CALL0 1966.99FALSE00
2026-05-15393CALL0 2664.1FALSE00
2026-05-15401.8CALL10 10860.62FALSE1.80
2026-05-15412.21CALL0 1875.83FALSE00
2026-05-15421.3CALL0 2266.28FALSE00
2026-05-15450.98CALL6 26764.12FALSE0.980
2026-05-15500.57CALL48 21263.64FALSE0.570
2026-05-15550.53CALL0 6876.51FALSE00
2026-05-15150.31PUT2 077.81FALSE0.310
2026-05-15200.97PUT0 1273.56FALSE00
2026-05-15231.97PUT17 273.22FALSE1.970
2026-05-15242.3PUT1 10272.38FALSE2.30
2026-05-15252.4PUT0 2168.79FALSE00
2026-05-15262.8PUT0 9269.86FALSE00
2026-05-15272.98PUT0 1068.71FALSE00
2026-05-15284.04PUT2 1370.72FALSE4.040
2026-05-15294.2PUT0 322870.22FALSE00
2026-05-15304.9PUT170 28966.96TRUE4.90
2026-05-15314.7PUT0 13673.34TRUE00
2026-05-15325.13PUT0 2065.69TRUE00
2026-05-15336.35PUT0 066.2TRUE00
2026-05-15347.3PUT0 256.85TRUE00
2026-05-15357.4PUT0 1162.39TRUE00
2026-05-15367.2PUT0 163.2TRUE00
2026-05-15377.7PUT0 1069.82TRUE00
2026-05-15380PUT0 065.46TRUE00
2026-05-15398.7PUT0 1666.19TRUE00
2026-05-154012.02PUT10 1065.3TRUE12.020
2026-05-154110.2PUT0 764.21TRUE00
2026-05-15420PUT0 064.06TRUE00
2026-05-154515.1PUT0 363.84TRUE00
2026-05-155020.13PUT0 20071.57TRUE00
2026-05-15550PUT0 062.27TRUE00
2026-08-212012CALL0 1569.96TRUE00
2026-08-212311.72CALL0 166.86TRUE00
2026-08-21240CALL0 066.36TRUE00
2026-08-21250CALL0 067.46TRUE00
2026-08-21268.05CALL98 069.34TRUE8.050
2026-08-21278.54CALL0 163.57TRUE00
2026-08-21287.8CALL0 164.8TRUE00
2026-08-21297.59CALL0 664.54TRUE00
2026-08-21306.95CALL0 663.99FALSE00
2026-08-21310CALL0 063.74FALSE00
2026-08-21325.79CALL0 163.25FALSE00
2026-08-21335.5CALL0 1363.32FALSE00
2026-08-21344.6CALL0 1063.17FALSE00
2026-08-21354.4CALL0 568.46FALSE00
2026-08-21360CALL0 062.21FALSE00
2026-08-21370CALL0 061.69FALSE00
2026-08-21380CALL0 061.81FALSE00
2026-08-21393.68CALL0 1560.62FALSE00
2026-08-21404.15CALL0 658.62FALSE00
2026-08-21452.3CALL0 163.44FALSE00
2026-08-21201.7PUT2 568.37FALSE0.10.06
2026-08-21232.5PUT0 363.87FALSE00
2026-08-21243.05PUT0 365.49FALSE00
2026-08-21250PUT0 063.29FALSE00
2026-08-21263.5PUT0 163.69FALSE00
2026-08-21273.9PUT0 171.77FALSE00
2026-08-21280PUT0 064.53FALSE00
2026-08-21290PUT0 064.15FALSE00
2026-08-21305.5PUT0 563.22TRUE00
2026-08-21316.08PUT0 463.13TRUE00
2026-08-21320PUT0 062.77TRUE00
2026-08-21330PUT0 062.16TRUE00
2026-08-21340PUT0 062.4TRUE00
2026-08-21350PUT0 061.86TRUE00
2026-08-21360PUT0 061.64TRUE00
2026-08-21370PUT0 061.2TRUE00
2026-08-21380PUT0 061.11TRUE00
2026-08-21390PUT0 060.82TRUE00
2026-08-21400PUT0 060.9TRUE00
2026-08-21450PUT0 059.23TRUE00
2027-01-151317.4CALL6 16867.56TRUE17.40
2027-01-151516.93CALL11 62987.78TRUE0.450.03
2027-01-151813.87CALL2 14767.99TRUE13.870
2027-01-152012.37CALL6 63964.21TRUE-0.63-0.05
2027-01-152211.4CALL42 65266.29TRUE-0.65-0.05
2027-01-15259.8CALL1 73565.24TRUE9.80
2027-01-15279.35CALL0 20862.75TRUE00
2027-01-15306.77CALL1 41356.68FALSE6.770
2027-01-15327.5CALL0 10966.62FALSE00
2027-01-15355.6CALL13 232460.77FALSE-0.56-0.09
2027-01-15375.5CALL0 20362.37FALSE00
2027-01-15404.1CALL26 87560.74FALSE-0.45-0.1
2027-01-15424.3CALL0 6863.41FALSE00
2027-01-15453.71CALL0 102263.84FALSE00
2027-01-15473CALL1 30559.97FALSE-0.3-0.09
2027-01-15502.32CALL20 63657.33FALSE2.320
2027-01-15552.01CALL0 18156.03FALSE00
2027-01-15602CALL5 157664.35FALSE20
2027-01-15131.12PUT0 3798.79FALSE00
2027-01-15151.23PUT1 10170.48FALSE-0.13-0.1
2027-01-15182.15PUT0 6972.86FALSE00
2027-01-15202.53PUT1 11265.75FALSE-0.03-0.01
2027-01-15223.35PUT0 12465.86FALSE00
2027-01-15254.3PUT0 157060.63FALSE00
2027-01-15275.5PUT0 10863.69FALSE00
2027-01-15306.45PUT1 26955.82TRUE6.450
2027-01-15328.21PUT0 1862.4TRUE00
2027-01-15359.3PUT0 171360.1TRUE00
2027-01-153710.41PUT0 1460.72TRUE00
2027-01-154013.33PUT0 19159.82TRUE00
2027-01-154214.32PUT0 17262.33TRUE00
2027-01-154517.1PUT0 49156.87TRUE00
2027-01-15470PUT0 056.98TRUE00
2027-01-155021.2PUT0 34052.74TRUE00
2027-01-155525.2PUT0 7061.34TRUE00
2027-01-156029.5PUT0 1264.94TRUE00
2028-01-211518.4CALL0 458.23TRUE00
2028-01-212016.2CALL0 4564.43TRUE00
2028-01-21230CALL0 063.14TRUE00
2028-01-212514.6CALL0 20261.75TRUE00
2028-01-212812.6CALL0 4067.96TRUE00
2028-01-213011CALL0 11466.17FALSE00
2028-01-213213.6CALL0 28766.19FALSE00
2028-01-213510.81CALL0 3656.89FALSE00
2028-01-21370CALL0 057.98FALSE00
2028-01-21408.6CALL0 1363.2FALSE00
2028-01-21420CALL0 056.74FALSE00
2028-01-21456.2CALL19 94658.46FALSE-0.5-0.07
2028-01-21505.23CALL0 14261.73FALSE00
2028-01-21556CALL0 2552.49FALSE00
2028-01-21150PUT0 0100.07FALSE00
2028-01-21204.3PUT0 857.92FALSE00
2028-01-21230PUT0 062.82FALSE00
2028-01-21256.2PUT0 462.24FALSE00
2028-01-21288.5PUT0 362.67FALSE00
2028-01-21309.7PUT4 9663.74TRUE0.50.05
2028-01-21329.75PUT0 061.47TRUE00
2028-01-213512.47PUT0 058.77TRUE00
2028-01-213712.27PUT0 357.8TRUE00
2028-01-214013PUT0 1558.17TRUE00
2028-01-21420PUT0 058.09TRUE00
2028-01-214518PUT0 155.96TRUE00
2028-01-215023.3PUT0 6955.48TRUE00
2028-01-215526.29PUT0 455.37TRUE00

Latest TGTX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST987$4.135
Jun 13, 2022 7:59 PM EST93$4.14
Jun 13, 2022 7:59 PM EST1$4.14
Jun 13, 2022 7:59 PM EST10$4.14
Jun 13, 2022 7:59 PM EST200$4.135

TG Therapeutics, Inc (TGTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1001316/000000000018021923/0000000000-18-021923-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375119000238/0000093751-19-000238-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375120000475/0000093751-20-000475-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719006548/0000215457-19-006548-index.htm
2019-06-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719008047/0000215457-19-008047-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506618001636/0000315066-18-001636-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506619001380/0000315066-19-001380-index.htm
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506620001583/0000315066-20-001583-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000083423720008183/0000834237-20-008183-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266419001008/0000902664-19-001008-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266420001111/0000902664-20-001111-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920021910/0001104659-20-021910-index.htm
2020-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920058131/0001104659-20-058131-index.htm
2020-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920072021/0001104659-20-072021-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2020-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080593/0001104659-20-080593-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000110465920092406/0001104659-20-092406-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-05-31PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036119010173/0001140361-19-010173-index.htm
2020-05-29PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036120012674/0001140361-20-012674-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000114420419008306/0001144204-19-008306-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266118000780/0001172661-18-000780-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000823/0001172661-19-000823-index.htm
2019-03-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000927/0001172661-19-000927-index.htm
2020-01-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000001/0001172661-20-000001-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000786/0001172661-20-000786-index.htm
2018-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518195773/0001193125-18-195773-index.htm
2018-07-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518215834/0001193125-18-215834-index.htm
2019-03-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924419000034/0001319244-19-000034-index.htm
2020-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924420000018/0001319244-20-000018-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000155837020001897/0001558370-20-001897-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020001925/0001558370-20-001925-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020002992/0001558370-20-002992-index.htm
2020-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020002997/0001558370-20-002997-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004647/0001558370-20-004647-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004651/0001558370-20-004651-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004722/0001558370-20-004722-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020005097/0001558370-20-005097-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006304/0001558370-20-006304-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006314/0001558370-20-006314-index.htm
2020-05-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006630/0001558370-20-006630-index.htm
2020-05-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006795/0001558370-20-006795-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006811/0001558370-20-006811-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020007744/0001558370-20-007744-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020010225/0001558370-20-010225-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020012661/0001558370-20-012661-index.htm
2018-02-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418001025/0001654954-18-001025-index.htm
2018-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418002262/0001654954-18-002262-index.htm
2018-03-1510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495418002638/0001654954-18-002638-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004295/0001654954-18-004295-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004519/0001654954-18-004519-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004521/0001654954-18-004521-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004821/0001654954-18-004821-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418005046/0001654954-18-005046-index.htm
2018-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006261/0001654954-18-006261-index.htm
2018-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006381/0001654954-18-006381-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006609/0001654954-18-006609-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006703/0001654954-18-006703-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006743/0001654954-18-006743-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006777/0001654954-18-006777-index.htm
2018-06-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006935/0001654954-18-006935-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2018-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495418007460/0001654954-18-007460-index.htm
2018-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007816/0001654954-18-007816-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418008559/0001654954-18-008559-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418008750/0001654954-18-008750-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418010436/0001654954-18-010436-index.htm
2018-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418011171/0001654954-18-011171-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418012263/0001654954-18-012263-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418012303/0001654954-18-012303-index.htm
2018-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418013524/0001654954-18-013524-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000641/0001654954-19-000641-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002047/0001654954-19-002047-index.htm
2019-02-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002091/0001654954-19-002091-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002189/0001654954-19-002189-index.htm
2019-03-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002274/0001654954-19-002274-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002276/0001654954-19-002276-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419003766/0001654954-19-003766-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005036/0001654954-19-005036-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005037/0001654954-19-005037-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005419/0001654954-19-005419-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005592/0001654954-19-005592-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419005680/0001654954-19-005680-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007297/0001654954-19-007297-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419009109/0001654954-19-009109-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419009176/0001654954-19-009176-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495419010203/0001654954-19-010203-index.htm
2019-09-05RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010400/0001654954-19-010400-index.htm
2019-09-05S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010402/0001654954-19-010402-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010620/0001654954-19-010620-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012023/0001654954-19-012023-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012611/0001654954-19-012611-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419012751/0001654954-19-012751-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419013703/0001654954-19-013703-index.htm
2019-12-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419014167/0001654954-19-014167-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419014209/0001654954-19-014209-index.htm
2018-07-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1001316/999999999518001856/9999999995-18-001856-index.htm
2018-04-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718005345/9999999997-18-005345-index.htm
2018-09-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718007926/9999999997-18-007926-index.htm

TG Therapeutics, Inc (TGTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of TG Therapeutics, Inc (TGTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 713%
Institutional Ownership: 6724%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-17WILLIAM JAMES KENNEDYDirectorBuy27,048.00102,378.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2020-06-22WILLIAM JAMES KENNEDYDirectorBuy15,000.00109,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2018-06-26MICHAEL S WEISSCEO and PresidentBuy1,018,011.0011,648,805.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-26Kenneth HobermanDirectorBuy15,000.00116,905.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-06-26Yann EchelardDirectorBuy15,000.00117,068.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-26Laurence N CharneyDirectorBuy15,000.00118,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2019-09-17DANIEL HUMEDirectorBuy27,048.00119,507.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2018-06-26MARK SCHOENEBAUMDirectorBuy15,000.00125,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2020-09-09RA CAPITAL MANAGEMENT, L.P.10% Share HolderSell158,589.0025.814,092,738.0412,629,868.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-06-13MICHAEL S WEISSCEO and PresidentBuy1,179,380.0012,828,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-26MICHAEL S WEISSCEO and PresidentBuy50,000.007.04351,750.0012,878,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2020-06-22DANIEL HUMEDirectorBuy15,000.00134,507.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2019-09-17Kenneth HobermanDirectorBuy27,048.00143,953.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-09-17Yann EchelardDirectorBuy27,048.00144,116.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2020-06-22MICHAEL S WEISSCEO and PresidentBuy1,556,029.0014,434,214.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2019-09-17Laurence N CharneyDirectorBuy27,048.00145,997.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2020-06-22Kenneth HobermanDirectorBuy15,000.00158,953.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-22Yann EchelardDirectorBuy15,000.00159,116.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-22Laurence N CharneyDirectorBuy15,000.00160,997.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2019-07-01Sean A PowerCFO, Secretary and TreasurerSell17,654.008.47149,529.38383,338.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-01-02Sean A PowerCFO, Secretary and TreasurerSell37,275.004.13153,945.75400,992.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy50,000.00433,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2018-07-03Sean A PowerCFO, Secretary and TreasurerSell35,000.0013.19461,650.00438,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-02Sean A PowerCFO, Secretary and TreasurerSell12,191.0013.26161,652.66473,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-06-14WILLIAM JAMES KENNEDYDirectorSell25,071.0013.45337,204.9560,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy200,000.00633,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-06-22Sagar LonialDirectorBuy65,000.0065,000.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-06-26WILLIAM JAMES KENNEDYDirectorBuy15,000.0075,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-26DANIEL HUMEDirectorBuy15,000.0092,459.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2020-06-17WILLIAM JAMES KENNEDYDirectorSell7,745.0018.27141,501.1594,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm